Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach.

Critical Reviews in Oncology/hematology
John M FitzpatrickMichael Chrisofos

Abstract

A multidisciplinary panel of 20 international experts, including urologists, radiation oncologists, and medical oncologists, convened during the Advanced Prostate Cancer Multidisciplinary Team meeting in Rome, Italy, in January 2007, to discuss the multidisciplinary team approach and current patterns of care for patients with hormone-refractory prostate cancer (HRPC). During the meeting, the experts discussed several definitions currently used in prostate cancer management, including those for senior adult patients. In addition, the panel reviewed a series of patient case studies in order to provide feedback on current treatment practices and to identify possible strategies for best practice. It was stressed that treatment decisions for senior adult patients should not be based solely on patient age. Additionally, although historically treatment decisions for advanced prostate cancer have focused on palliative care, given the survival benefit associated with docetaxel-based chemotherapy across patient subgroups, more men are likely to be offered chemotherapy for advanced-stage disease in the future.

References

May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Markus GraefenMichael W Kattan
Sep 18, 2003·Journal of the National Cancer Institute·Anthony V D'AmicoMing-Hui Chen
Jun 3, 2004·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Jul 28, 2005·JAMA : the Journal of the American Medical Association·Stephen J FreedlandAlan W Partin
Aug 16, 2005·Lancet·Michel BollaUNKNOWN European Organization for Research and Treatment of Cancer
Feb 7, 2006·Cancer Treatment Reviews·Guru SonpavdeWilliam R Berry
Apr 20, 2006·Journal of the National Cancer Institute·Daniel P PetrylakE David Crawford
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J SmallRobert M Hershberg
Jul 22, 2006·European Urology·Laura PoissonnierAlbert Gelet
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J StephensonPeter T Scardino
Sep 27, 2006·European Urology·Luigi Dogliotti
Nov 16, 2006·JAMA : the Journal of the American Medical Association·Ian M ThompsonE David Crawford
Mar 16, 2007·Neoplasia : an International Journal for Oncology Research·Yu-Ming ChangChristopher P Evans
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric J SmallJonathan W Simons
Sep 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J ArmstrongMario Eisenberger
Oct 9, 2007·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
Nov 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew J ArmstrongMario Eisenberger
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominik R BertholdIan F Tannock

❮ Previous
Next ❯

Citations

Nov 4, 2011·The Oncologist·Oliver SartorJohann Sebastian de Bono
Jan 7, 2011·Clinical Genitourinary Cancer·Andrea ZiviJohann De-Bono
Dec 4, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Riccardo ValdagniAlberto Costa
May 18, 2012·The Prostate·Konstantin V GolovineVladimir M Kolenko
Jun 21, 2015·Critical Reviews in Oncology/hematology·Riccardo ValdagniAlberto Costa
Sep 18, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·David Díaz-CarballoDirk Strumberg
Nov 2, 2013·The Lancet Oncology·Scott WilliamsUNKNOWN Asian Oncology Summit 2013
Feb 13, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MassardK Fizazi
Jan 6, 2012·The American Journal of Hospice & Palliative Care·Hanna A Zaghloul, Jose R Murillo
Nov 4, 2011·Nature Reviews. Clinical Oncology·Christophe MassardKarim Fizazi
Mar 17, 2011·Expert Opinion on Pharmacotherapy·Dirk P J MichielsenLouis Denis
Jun 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christophe Massard, Karim Fizazi
Sep 3, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Muralimohan YepuruRamesh Narayanan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Lancet
Howard I ScherProstate Cancer Foundation/Department of Defense Prostate Cancer Clinical Trials Consortium
© 2022 Meta ULC. All rights reserved